You are here:
17 November 2021 / deal

Loyens & Loeff advised Coloplast on acquisition of Atos Medical

Loyens & Loeff has advised Coloplast A/S, a multinational company listed on Nasdaq Copenhagen.

Coloplast A/S develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care, on its acquisition of the Atos Medical group, the global market leader in laryngectomy, for EUR 2.155 billion (around DKK 16 billion) from PAI Partners, a global private equity firm headquartered in Paris. Closing of the transaction is subject to customary regulatory approvals and anticipated to occur in Q2 2021/22.

The Loyens & Loeff team was lead by Frank Leijdesdorff, Dries Fransen van de Putte and Marc Wiggers. Kromann Reumert acted as lead counsel for Coloplast.



Swiss Special Purpose Acquisition Company

Frequently Asked Questions II read more
The Legal 500 Private Equity Country Comparative Guide 2021

The Legal 500 Private Equity Country Comparative Guide 2021

Loyens & Loeff has contributed to the publication of the 2021 edition. read more
Club Deals article - business meeting

Club deals: the essentials of structuring co-investments

This article discusses what to consider when structuring a co-investment vehicle via a Luxembourg company. read more